AI Insight
Researchers at Mass General Brigham Heart and Vascular Institute identified a significant association between hepatic steatosis (fatty liver disease) and adverse cardiovascular outcomes. Individuals with this condition were found to carry a greater burden of noncalcified coronary plaque, which is considered more vulnerable to rupture and therefore more dangerous. Furthermore, these individuals experienced cardiovascular events at nearly twice the rate of those without hepatic steatosis.
Why it matters
These findings suggest that fatty liver disease may serve as a clinically relevant marker for elevated cardiovascular risk, potentially prompting earlier cardiac screening and intervention in affected patients. Given the widespread prevalence of hepatic steatosis globally, this link could have substantial implications for preventive cardiology practice.
Researchers at Mass General Brigham Heart and Vascular Institute found that people with hepatic steatosis, commonly called “fatty liver disease,” have a higher amount of noncalcified, rupture-prone coronary plaque and face nearly twice the rate of cardiovascular events compared to those without steatosis.
Source: Study illuminates link between fatty liver disease and cardiovascular events